BR112023017612A2 - Compostos agonistas do receptor beta do hormônio da tireoide - Google Patents
Compostos agonistas do receptor beta do hormônio da tireoideInfo
- Publication number
- BR112023017612A2 BR112023017612A2 BR112023017612A BR112023017612A BR112023017612A2 BR 112023017612 A2 BR112023017612 A2 BR 112023017612A2 BR 112023017612 A BR112023017612 A BR 112023017612A BR 112023017612 A BR112023017612 A BR 112023017612A BR 112023017612 A2 BR112023017612 A2 BR 112023017612A2
- Authority
- BR
- Brazil
- Prior art keywords
- thyroid hormone
- agonist compounds
- receptor agonist
- beta receptor
- beta
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 title abstract 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 title abstract 2
- 108010079452 beta Adrenergic Receptors Proteins 0.000 title abstract 2
- 239000000018 receptor agonist Substances 0.000 title abstract 2
- 229940044601 receptor agonist Drugs 0.000 title abstract 2
- 239000005495 thyroid hormone Substances 0.000 title abstract 2
- 229940036555 thyroid hormone Drugs 0.000 title abstract 2
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000008484 agonism Effects 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 230000001668 ameliorated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108091008762 thyroid hormone receptors ß Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
compostos agonistas do receptor beta do hormônio da tireoide. são fornecidos, neste documento, compostos, preferencialmente compostos agonistas do receptor beta do hormônio da tireoide (thr beta), composições destes, e métodos de sua preparação, e métodos de agonismo do thr beta e métodos para tratar distúrbios amenizados pela ativação do thr beta.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156227P | 2021-03-03 | 2021-03-03 | |
| PCT/US2022/018575 WO2022187403A1 (en) | 2021-03-03 | 2022-03-02 | Thyroid hormone receptor beta agonist compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023017612A2 true BR112023017612A2 (pt) | 2023-12-05 |
Family
ID=83154837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023017612A BR112023017612A2 (pt) | 2021-03-03 | 2022-03-02 | Compostos agonistas do receptor beta do hormônio da tireoide |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240059682A1 (pt) |
| EP (1) | EP4301357A1 (pt) |
| JP (1) | JP2024510935A (pt) |
| KR (1) | KR20230152095A (pt) |
| CN (1) | CN117120051A (pt) |
| AU (1) | AU2022228569A1 (pt) |
| BR (1) | BR112023017612A2 (pt) |
| CA (1) | CA3212130A1 (pt) |
| CL (1) | CL2023002601A1 (pt) |
| CO (1) | CO2023012684A2 (pt) |
| IL (1) | IL305495A (pt) |
| MX (1) | MX2023010324A (pt) |
| PE (1) | PE20240097A1 (pt) |
| WO (1) | WO2022187403A1 (pt) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL54474A (en) * | 1977-04-12 | 1982-04-30 | Ciba Geigy Ag | Benzimidazole derivatives,their preparation and anthelmintic compositions containing them |
| CN105477636B (zh) * | 2015-10-16 | 2019-09-17 | 厦门大学 | 使用阿维菌素及其衍生物治疗代谢疾病的方法 |
| TW202220968A (zh) * | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| JP2021535207A (ja) * | 2018-08-24 | 2021-12-16 | ターンズ・インコーポレイテッドTerns, Inc. | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
| WO2020061086A2 (en) * | 2018-09-18 | 2020-03-26 | Terns, Inc. | Compounds for treating certain leukemias |
| WO2020077123A1 (en) * | 2018-10-12 | 2020-04-16 | Terns, Inc. | Thyroid hormone receptor beta agonist compounds |
| CN111320609A (zh) * | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| PE20220255A1 (es) * | 2019-05-08 | 2022-02-16 | Aligos Therapeutics Inc | Moduladores de thr y metodos de uso de estos |
-
2022
- 2022-03-02 US US18/548,650 patent/US20240059682A1/en active Pending
- 2022-03-02 CA CA3212130A patent/CA3212130A1/en active Pending
- 2022-03-02 EP EP22764006.7A patent/EP4301357A1/en active Pending
- 2022-03-02 JP JP2023553065A patent/JP2024510935A/ja active Pending
- 2022-03-02 IL IL305495A patent/IL305495A/en unknown
- 2022-03-02 KR KR1020237032893A patent/KR20230152095A/ko unknown
- 2022-03-02 CN CN202280027156.1A patent/CN117120051A/zh active Pending
- 2022-03-02 AU AU2022228569A patent/AU2022228569A1/en active Pending
- 2022-03-02 BR BR112023017612A patent/BR112023017612A2/pt unknown
- 2022-03-02 WO PCT/US2022/018575 patent/WO2022187403A1/en active Application Filing
- 2022-03-02 PE PE2023002483A patent/PE20240097A1/es unknown
- 2022-03-02 MX MX2023010324A patent/MX2023010324A/es unknown
-
2023
- 2023-09-01 CL CL2023002601A patent/CL2023002601A1/es unknown
- 2023-09-26 CO CONC2023/0012684A patent/CO2023012684A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2023012684A2 (es) | 2023-10-19 |
| EP4301357A1 (en) | 2024-01-10 |
| AU2022228569A1 (en) | 2023-10-12 |
| CN117120051A (zh) | 2023-11-24 |
| IL305495A (en) | 2023-10-01 |
| KR20230152095A (ko) | 2023-11-02 |
| CA3212130A1 (en) | 2022-09-09 |
| PE20240097A1 (es) | 2024-01-18 |
| MX2023010324A (es) | 2023-11-09 |
| CL2023002601A1 (es) | 2024-03-22 |
| US20240059682A1 (en) | 2024-02-22 |
| WO2022187403A1 (en) | 2022-09-09 |
| JP2024510935A (ja) | 2024-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020011562A (es) | Agonistas del receptor de la hormona tiroidea y usos de los mismos. | |
| BR112021019334A2 (pt) | Anticorpos de cadeia pesada que se ligam ao psma | |
| MY194619A (en) | Glucocorticoid receptor agonist and immunoconjugates thereof | |
| JOP20190248A1 (ar) | بروتينات ربط مولد ضد trem2 واستخداماته | |
| PA8805801A1 (es) | Agonistas novedosos de los receptores de glucorticoides | |
| CL2021001075A1 (es) | Agonista del receptor de glucocorticoides e inmunoconjugados de este solicitud divisional de 202001452) | |
| CL2015003290A1 (es) | Nuevos agonistas del receptor de somatostatina subtipo 4 (sstr4). | |
| MX2021015160A (es) | Anticuerpos de receptor de peptido natriuretico 1 y metodos de uso. | |
| EA201900562A1 (ru) | Бис-октагидрофенантрена карбоксамиды и их белковые конъюгаты | |
| CL2018003608A1 (es) | Anticuerpo aislado o fragmento de unión a antígeno del mismo que se une específicamente interleucina-25 hjumana (il-2525); composición farmacéutica que lo comprende; uso de dicha composición farmacéutica para tratar una enfermedad o trastorno asociado con la actividad o expresión de il-25. (divisional solicitud 201700703) | |
| ECSP21090414A (es) | Anticuerpos multiespecíficos de cadena pesada que se unen a cd22 y cd3 | |
| CL2021003273A1 (es) | Composición farmacéutica parenteral del agonista dual glp1/2 | |
| CO2021009129A2 (es) | Tubulisinas y conjugados de proteína-tubulisina | |
| MX2023008330A (es) | Agonistas del receptor dual gip/glp-1 de molécula pequeña, composiciones farmacéuticas y preparación de las mismas para usarse en el tratamiento de trastornos metabólicos y hepáticos. | |
| BR112023017612A2 (pt) | Compostos agonistas do receptor beta do hormônio da tireoide | |
| EA201992883A1 (ru) | АНТИТЕЛА К TrkB | |
| CL2023001493A1 (es) | Anticuerpos anti-ly6g6d y métodos de uso. | |
| MX2018002510A (es) | Combinacion farmaceutica para trastornos del estado de animo. | |
| EA202092895A1 (ru) | Агонистические антитела против cd226 | |
| WO2024020164A3 (en) | Glucocorticoid receptor agonists and conjugates thereof | |
| AR111914A1 (es) | Proteínas de unión a antígenos trem2 y usos de estas | |
| WO2018187282A3 (en) | Therapeutic sigma-1 receptor agonists for treating long qt syndrome type-1, type-6, type-8 and related channelopathies | |
| EA202192631A1 (ru) | Противораковые соединения, нацеленные на ядерные гормональные рецепторы | |
| EA202090257A1 (ru) | Антитела-агонисты, которые связывают cd137 человека, и варианты их применения |